US Stock MarketDetailed Quotes

MGRX Mangoceuticals

Watchlist
  • 0.235
  • +0.007+3.16%
Close Sep 26 16:00 ET
  • 0.242
  • +0.007+2.89%
Post 20:01 ET
7.03MMarket Cap-751P/E (TTM)

Mangoceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
11.42%-1.58M
45.19%-991.13K
-419.66%-7M
-161.37%-1.7M
-184.96%-1.71M
-2,185.38%-1.78M
-9,570.06%-1.81M
-1.35M
-3,607.53%-649.56K
-600.35K
Net income from continuing operations
-4.70%-2.39M
7.55%-2.37M
-361.07%-9.21M
-281.21%-2.57M
-84.50%-1.8M
-593.21%-2.28M
-12,966.41%-2.56M
---2M
-3,705.75%-673.66K
---975.32K
Operating gains losses
----
----
----
----
----
----
----
---151.82K
----
----
Depreciation and amortization
-48.51%3.21K
2.33%6.22K
544.29%24.89K
62.85%6.29K
--6.29K
--6.22K
--6.08K
--3.86K
--3.86K
--0
Other non cash items
113.43%808.4K
-40.65%416.5K
178.88%1.52M
591.99%358.9K
-68.28%84.75K
67.16%378.77K
78,838.13%701.76K
--546.54K
28,554.70%51.87K
--267.2K
Change In working capital
-634.46%-289.57K
4,789.18%915.8K
120.00%41.51K
35.98%76.04K
-11.48%-69.17K
116.72%54.18K
---19.53K
--18.87K
--55.92K
---62.05K
-Change in receivables
----
----
131.55%54.98K
----
----
----
----
---174.24K
----
----
-Change in inventory
101.84%433
--4.05K
---18.5K
--3.08K
--1.91K
---23.49K
--0
--0
--0
--0
-Change in prepaid assets
317.60%46.75K
104.62%902
-71.53%-49.21K
159.40%23.43K
16.16%-31.62K
---21.49K
---19.53K
---28.69K
--9.03K
---37.72K
-Change in payables and accrued expense
-436.02%-335.81K
--911.79K
204.92%110.97K
40.26%50.1K
-60.59%-39.07K
299.75%99.94K
--0
--36.39K
--35.72K
---24.33K
-Change in other current assets
-45.42%14.78K
--14.47K
----
----
--13.73K
--27.08K
--0
----
----
--0
-Change in other current liabilities
43.57%-15.72K
---15.41K
-130.60%-56.73K
-107.95%-14.75K
---14.12K
---27.86K
--0
--185.41K
--185.41K
--0
Cash from discontinued investing activities
Operating cash flow
11.42%-1.58M
45.19%-991.13K
-419.66%-7M
-161.37%-1.7M
-184.96%-1.71M
-2,185.67%-1.78M
-9,564.90%-1.81M
---1.35M
-3,607.53%-649.56K
---600.35K
Investing cash flow
Cash flow from continuing investing activities
65K
0
91.84%-3.52K
0
0
0
-3.52K
-43.1K
-40.57K
-2.53K
Net PPE purchase and sale
--65K
--0
91.84%-3.52K
--0
--0
--0
---3.52K
---43.1K
---40.57K
---2.53K
Cash from discontinued investing activities
Investing cash flow
--65K
--0
91.84%-3.52K
--0
--0
--0
---3.52K
---43.1K
---40.57K
---2.53K
Financing cash flow
Cash flow from continuing financing activities
131.99%1.99M
-94.65%267.5K
244.26%7.06M
140.24%1.2M
0
3,337.79%857.04K
9,900.00%5M
2.05M
1,146.57%499.5K
1.48M
Net issuance payments of debt
159.72%100K
--87.5K
-435.39%-167.46K
--0
--0
-771.72%-167.46K
--0
--49.93K
--0
---25K
Net common stock issuance
--388.27K
-96.40%180K
210.00%6.2M
140.24%1.2M
--0
--0
--5M
--2M
62,337.50%499.5K
--1.5M
Proceeds from stock option exercised by employees
----
----
--1.02M
--0
--0
----
----
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
131.99%1.99M
-94.65%267.5K
244.26%7.06M
140.24%1.2M
--0
3,337.79%857.04K
9,900.00%5M
--2.05M
1,146.57%499.5K
--1.48M
Net cash flow
Beginning cash position
-99.60%15.31K
8.22%739.01K
2,928.20%682.86K
41.59%1.24M
339,473.16%2.95M
7,089.89%3.87M
2,928.20%682.86K
--22.55K
--873.49K
--868
Current changes in cash
151.54%476.03K
-122.70%-723.63K
-91.50%56.15K
-161.10%-497.74K
-296.05%-1.71M
-1,643.46%-923.54K
10,089.13%3.19M
--660.31K
-945.37%-190.63K
--872.62K
Effect of exchange rate changes
---1.1K
---70
----
----
----
--0
--0
----
----
----
End cash Position
-83.37%490.24K
-99.60%15.31K
8.22%739.01K
8.22%739.01K
41.59%1.24M
339,473.16%2.95M
7,089.89%3.87M
--682.86K
2,928.20%682.86K
--873.49K
Free cash flow
11.42%-1.58M
45.30%-991.13K
-403.80%-7M
-146.00%-1.7M
-183.76%-1.71M
-2,185.67%-1.78M
-9,583.70%-1.81M
---1.39M
-3,839.10%-690.13K
---602.88K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 11.42%-1.58M45.19%-991.13K-419.66%-7M-161.37%-1.7M-184.96%-1.71M-2,185.38%-1.78M-9,570.06%-1.81M-1.35M-3,607.53%-649.56K-600.35K
Net income from continuing operations -4.70%-2.39M7.55%-2.37M-361.07%-9.21M-281.21%-2.57M-84.50%-1.8M-593.21%-2.28M-12,966.41%-2.56M---2M-3,705.75%-673.66K---975.32K
Operating gains losses -------------------------------151.82K--------
Depreciation and amortization -48.51%3.21K2.33%6.22K544.29%24.89K62.85%6.29K--6.29K--6.22K--6.08K--3.86K--3.86K--0
Other non cash items 113.43%808.4K-40.65%416.5K178.88%1.52M591.99%358.9K-68.28%84.75K67.16%378.77K78,838.13%701.76K--546.54K28,554.70%51.87K--267.2K
Change In working capital -634.46%-289.57K4,789.18%915.8K120.00%41.51K35.98%76.04K-11.48%-69.17K116.72%54.18K---19.53K--18.87K--55.92K---62.05K
-Change in receivables --------131.55%54.98K-------------------174.24K--------
-Change in inventory 101.84%433--4.05K---18.5K--3.08K--1.91K---23.49K--0--0--0--0
-Change in prepaid assets 317.60%46.75K104.62%902-71.53%-49.21K159.40%23.43K16.16%-31.62K---21.49K---19.53K---28.69K--9.03K---37.72K
-Change in payables and accrued expense -436.02%-335.81K--911.79K204.92%110.97K40.26%50.1K-60.59%-39.07K299.75%99.94K--0--36.39K--35.72K---24.33K
-Change in other current assets -45.42%14.78K--14.47K----------13.73K--27.08K--0----------0
-Change in other current liabilities 43.57%-15.72K---15.41K-130.60%-56.73K-107.95%-14.75K---14.12K---27.86K--0--185.41K--185.41K--0
Cash from discontinued investing activities
Operating cash flow 11.42%-1.58M45.19%-991.13K-419.66%-7M-161.37%-1.7M-184.96%-1.71M-2,185.67%-1.78M-9,564.90%-1.81M---1.35M-3,607.53%-649.56K---600.35K
Investing cash flow
Cash flow from continuing investing activities 65K091.84%-3.52K000-3.52K-43.1K-40.57K-2.53K
Net PPE purchase and sale --65K--091.84%-3.52K--0--0--0---3.52K---43.1K---40.57K---2.53K
Cash from discontinued investing activities
Investing cash flow --65K--091.84%-3.52K--0--0--0---3.52K---43.1K---40.57K---2.53K
Financing cash flow
Cash flow from continuing financing activities 131.99%1.99M-94.65%267.5K244.26%7.06M140.24%1.2M03,337.79%857.04K9,900.00%5M2.05M1,146.57%499.5K1.48M
Net issuance payments of debt 159.72%100K--87.5K-435.39%-167.46K--0--0-771.72%-167.46K--0--49.93K--0---25K
Net common stock issuance --388.27K-96.40%180K210.00%6.2M140.24%1.2M--0--0--5M--2M62,337.50%499.5K--1.5M
Proceeds from stock option exercised by employees ----------1.02M--0--0----------0--0--0
Cash from discontinued financing activities
Financing cash flow 131.99%1.99M-94.65%267.5K244.26%7.06M140.24%1.2M--03,337.79%857.04K9,900.00%5M--2.05M1,146.57%499.5K--1.48M
Net cash flow
Beginning cash position -99.60%15.31K8.22%739.01K2,928.20%682.86K41.59%1.24M339,473.16%2.95M7,089.89%3.87M2,928.20%682.86K--22.55K--873.49K--868
Current changes in cash 151.54%476.03K-122.70%-723.63K-91.50%56.15K-161.10%-497.74K-296.05%-1.71M-1,643.46%-923.54K10,089.13%3.19M--660.31K-945.37%-190.63K--872.62K
Effect of exchange rate changes ---1.1K---70--------------0--0------------
End cash Position -83.37%490.24K-99.60%15.31K8.22%739.01K8.22%739.01K41.59%1.24M339,473.16%2.95M7,089.89%3.87M--682.86K2,928.20%682.86K--873.49K
Free cash flow 11.42%-1.58M45.30%-991.13K-403.80%-7M-146.00%-1.7M-183.76%-1.71M-2,185.67%-1.78M-9,583.70%-1.81M---1.39M-3,839.10%-690.13K---602.88K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data